RBC Capital Maintains Sector Perform on Amgen, Raises Price Target to $256
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Gregory Renza maintains a 'Sector Perform' rating on Amgen (NASDAQ:AMGN) and raises the price target from $253 to $256.
November 02, 2023 | 5:27 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RBC Capital maintains a 'Sector Perform' rating on Amgen and raises the price target from $253 to $256.
The news is directly about Amgen and its price target being raised by RBC Capital. This suggests that the analyst sees potential in the stock, but the 'Sector Perform' rating indicates that they expect it to perform in line with the sector, not outperform it. This could have a neutral impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100